summ
r
decemb
cluster
patient
pneumonia
unknown
caus
link
seafood
wholesal
market
wuhan
china
previous
unknown
betacoronaviru
discov
use
unbias
sequenc
sampl
patient
pneumonia
human
airway
epitheli
cell
use
isol
novel
coronaviru
name
form
clade
within
subgenu
sarbecoviru
orthocoronavirina
subfamili
differ
merscov
sarscov
seventh
member
famili
coronavirus
infect
human
enhanc
surveil
investig
ongo
e
merg
reemerg
pathogen
global
challeng
public
health
coronavirus
envelop
rna
virus
distribut
broadli
among
human
mammal
bird
caus
respiratori
enter
hepat
neurolog
diseas
six
coronaviru
speci
known
caus
human
diseas
four
virus
preval
typic
caus
common
cold
symptom
immunocompet
individu
two
strain
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
zoonot
origin
link
sometim
fatal
ill
sarscov
causal
agent
sever
acut
respiratori
syndrom
outbreak
guangdong
provinc
china
merscov
pathogen
respons
sever
respiratori
diseas
outbreak
middl
east
given
high
preval
wide
distribut
coronavirus
larg
genet
divers
frequent
recombin
genom
increas
humananim
interfac
activ
novel
coronavirus
like
emerg
period
human
owe
frequent
crossspeci
infect
occasion
spillov
event
late
decemb
sever
local
health
facil
report
cluster
patient
pneumonia
unknown
caus
epidemiolog
link
seafood
wet
anim
wholesal
market
wuhan
hubei
provinc
china
decemb
chines
center
diseas
control
prevent
china
cdc
dispatch
rapid
respons
team
accompani
hubei
provinci
wuhan
citi
health
author
conduct
epidemiolog
etiolog
investig
report
result
investig
identifi
sourc
pneumonia
h
e
ne
w
e
ngl
nd
jou
r
na
l
f
e
dicin
cluster
describ
novel
coronaviru
detect
patient
pneumonia
whose
specimen
test
china
cdc
earli
stage
outbreak
also
describ
clinic
featur
pneumonia
two
patient
four
lower
respiratori
tract
sampl
includ
bronchoalveolarlavag
fluid
collect
patient
pneumonia
unknown
caus
identifi
wuhan
decemb
later
present
huanan
seafood
market
close
time
clinic
present
seven
bronchoalveolarlavag
fluid
specimen
collect
patient
beij
hospit
pneumonia
known
caus
serv
control
sampl
extract
nucleic
acid
clinic
sampl
includ
uninfect
cultur
serv
neg
control
perform
high
pure
viral
nucleic
acid
kit
describ
manufactur
roch
extract
nucleic
acid
sampl
test
virus
bacteria
polymeras
chain
reaction
pcr
use
pathofind
bv
lightcycl
realtim
pcr
system
accord
manufactur
instruct
sampl
analyz
pathogen
virus
bacteria
detail
supplementari
appendix
addit
unbias
highthroughput
sequenc
describ
previous
use
discov
microbi
sequenc
identifi
mean
describ
realtim
revers
transcript
pcr
rtpcr
assay
use
detect
viral
rna
target
consensu
rdrp
region
pan
describ
supplementari
appendix
bronchoalveolarlavag
fluid
sampl
collect
steril
cup
viru
transport
medium
ad
sampl
centrifug
remov
cellular
debri
supernat
inocul
human
airway
epitheli
cell
obtain
airway
specimen
resect
patient
undergo
surgeri
lung
cancer
confirm
specialpathogenfre
ng
human
airway
epitheli
cell
expand
plastic
substrat
gener
cell
subsequ
plate
densiti
cell
per
well
permeabl
transwellcol
diamet
support
human
airway
epitheli
cell
cultur
gener
airliquid
interfac
week
form
welldifferenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epithelium
prior
infect
apic
surfac
human
airway
epitheli
cell
wash
three
time
phosphatebuff
salin
supernat
bronchoalveolarlavag
fluid
sampl
inocul
onto
apic
surfac
cell
cultur
incub
unbound
viru
remov
wash
phosphatebuff
salin
minut
human
airway
epitheli
cell
maintain
airliquid
interfac
incub
carbon
dioxid
everi
hour
phosphatebuff
salin
appli
apic
surfac
human
airway
epitheli
cell
minut
incub
sampl
harvest
pseudostratifi
mucociliari
epithelium
cell
maintain
environ
apic
sampl
passag
dilut
vial
stock
new
cell
cell
monitor
daili
light
microscopi
cytopath
effect
rtpcr
presenc
viral
nucleic
acid
supernat
three
passag
apic
sampl
human
airway
epitheli
cell
prepar
transmiss
electron
microscopi
supernat
human
airway
epitheli
cell
cultur
show
cytopath
effect
collect
inactiv
paraformaldehyd
least
hour
ultracentrifug
sediment
viru
particl
enrich
supernat
neg
stain
filmcoat
grid
examin
human
airway
epitheli
cell
show
cytopath
effect
collect
fix
glutaraldehyd
fix
osmium
tetroxid
dehydr
grade
ethanol
embed
resin
section
nm
cut
resin
block
stain
uranyl
acet
lead
citrat
separ
neg
stain
grid
ultrathin
section
observ
transmiss
electron
microscopi
rna
extract
bronchoalveolarlavag
fluid
cultur
supernat
use
templat
clone
sequenc
genom
use
combin
illumina
sequenc
nanopor
sequenc
character
viru
genom
sequenc
read
assembl
contig
map
set
overlap
dna
segment
use
clc
genom
softwar
version
clc
bio
specif
primer
subsequ
design
pcr
rapid
amplif
cdna
end
use
fill
genom
gap
convent
sanger
sequenc
pcr
product
purifi
gel
sequenc
bigdy
termin
cycl
sequenc
kit
genet
analyz
accord
manufactur
instruct
multiplesequ
align
refer
sequenc
perform
use
muscl
phylogenet
analysi
complet
genom
perform
raxml
bootstrap
replic
gener
timerevers
model
use
nucleotid
substitut
model
three
adult
patient
present
sever
pneumonia
admit
hospit
wuhan
decemb
patient
woman
patient
man
patient
man
clinic
profil
avail
patient
patient
report
underli
chronic
medic
condit
report
fever
temperatur
cough
chest
discomfort
decemb
four
day
onset
ill
cough
chest
discomfort
worsen
fever
reduc
diagnosi
pneumonia
base
comput
tomograph
ct
scan
occup
retail
seafood
wholesal
market
patient
initi
report
fever
cough
decemb
respiratori
distress
develop
day
onset
ill
worsen
next
day
see
chest
radiograph
fig
time
mechan
ventil
start
frequent
visitor
seafood
wholesal
market
patient
recov
discharg
hospit
januari
patient
die
januari
biopsi
specimen
obtain
h
e
ne
w
e
ngl
nd
jou
r
na
l
f
e
dicin
three
bronchoalveolarlavag
sampl
collect
wuhan
jinyintan
hospit
decemb
specif
pathogen
includ
detect
clinic
specimen
patient
rna
extract
bronchoalveolarlavag
fluid
patient
use
templat
clone
sequenc
genom
use
combin
illumina
sequenc
nanopor
sequenc
viral
read
individu
specimen
obtain
contig
match
genom
lineag
b
genu
betacoronaviru
show
ident
bat
sarslik
cov
genom
publish
previous
posit
result
also
obtain
use
realtim
rtpcr
assay
rna
target
consensu
rdrp
region
pan
although
cycl
threshold
valu
higher
detect
sampl
viru
isol
clinic
specimen
perform
human
airway
epitheli
cell
vero
cell
line
isol
viru
name
determin
whether
viru
particl
could
visual
human
airway
epitheli
cell
mockinfect
human
airway
epitheli
cultur
examin
light
microscopi
daili
transmiss
electron
microscopi
day
inocul
cytopath
effect
observ
hour
inocul
surfac
layer
human
airway
epitheli
cell
lack
cilium
beat
seen
light
microcopi
center
focu
fig
specif
cytopath
effect
observ
vero
cell
line
day
inocul
electron
micrograph
negativestain
particl
gener
spheric
pleomorph
fig
diamet
vari
nm
viru
particl
quit
distinct
spike
nm
gave
virion
appear
solar
corona
extracellular
free
viru
particl
inclus
bodi
fill
viru
particl
membranebound
vesicl
cytoplasm
found
human
airway
epitheli
ultrathin
section
observ
morpholog
consist
coronavirida
famili
character
viru
de
novo
sequenc
genom
clinic
specimen
bronchoalveolarlavag
fluid
human
airway
epitheli
cell
viru
isol
obtain
illumina
nanopor
sequenc
novel
coronaviru
identifi
three
patient
two
nearli
fulllength
coronaviru
sequenc
obtain
bronchoalveolarlavag
fluid
betacov
one
fulllength
sequenc
obtain
viru
isol
patient
betacovwuhan
complet
genom
sequenc
three
novel
coronavirus
submit
gisaid
betacovwuhan
access
id
access
id
although
similar
betacoronavirus
detect
bat
fig
distinct
sarscov
merscov
three
coronavirus
wuhan
togeth
two
batderiv
sarslik
strain
form
distinct
clade
sarscov
strain
human
genet
similar
sarslik
coronavirus
bat
collect
southwestern
china
form
anoth
clade
within
subgenu
sarbecoviru
sinc
sequenc
ident
conserv
replicas
domain
orf
less
member
betacoronaviru
like
caus
agent
viral
pneumonia
wuhan
novel
betacoronaviru
belong
sarbecoviru
subgenu
coronavirida
famili
report
novel
cov
identifi
hospit
patient
wuhan
china
decemb
januari
evid
presenc
viru
includ
identif
bronchoalveolarlavag
fluid
three
patient
wholegenom
sequenc
direct
pcr
cultur
ill
like
caus
cov
name
novel
coronavirusinfect
pneumonia
ncip
complet
genom
submit
gisaid
phylogenet
analysi
reveal
fall
genu
betacoronaviru
includ
coronavirus
sarscov
bat
sarslik
cov
other
discov
human
bat
wild
anim
report
isol
viru
initi
descript
specif
cytopath
effect
morpholog
molecular
techniqu
use
success
identifi
infecti
agent
mani
year
unbias
highthroughput
sequenc
power
tool
discoveri
pathogen
nextgener
sequenc
bioinformat
chang
way
respond
infecti
diseas
outbreak
improv
understand
diseas
occurr
transmiss
acceler
identif
pathogen
promot
data
share
describ
report
use
molecular
techniqu
unbias
dna
sequenc
discov
novel
betacoronaviru
like
caus
sever
pneumonia
three
patient
wuhan
china
although
establish
human
airway
epitheli
cell
cultur
labor
intens
appear
valuabl
research
tool
analysi
human
respiratori
pathogen
studi
show
initi
propag
human
respiratori
secret
onto
human
airway
epitheli
cell
cultur
follow
transmiss
electron
microscopi
whole
genom
sequenc
cultur
supernat
success
use
visual
detect
new
human
coronaviru
possibl
elud
identif
tradit
approach
develop
accur
rapid
method
identifi
unknown
respiratori
pathogen
still
need
basi
analysi
three
complet
genom
obtain
studi
design
sever
specif
sensit
assay
target
n
e
region
genom
detect
viral
rna
clinic
specimen
primer
set
standard
oper
procedur
share
world
health
organ
intend
surveil
detect
infect
global
china
recent
data
show
detect
person
china
although
studi
fulfil
koch
postul
analys
provid
evid
implic
wuhan
outbreak
addit
evid
confirm
etiolog
signific
wuhan
outbreak
includ
identif
antigen
lung
tissu
patient
immunohistochem
analysi
detect
igm
igg
antivir
antibodi
serum
sampl
patient
two
time
point
demonstr
seroconvers
anim
monkey
experi
provid
evid
pathogen
critic
import
epidemiolog
investig
character
transmiss
mode
reproduct
interv
clinic
spectrum
result
infect
inform
refin
strategi
prevent
control
stop
spread
